Y-mAbs is a commercial-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. We have a broad and advanced product pipeline, including pivotal-stage product candidates against a range of targets.
Our mission is to become the world leader in developing better and safer antibody-based oncology products addressing clear unmet pediatric and adult medical needs.
Helps us keep the website stable, secure, and usable, so core features such as navigation and login work as expected.
Read more
Session handling and login
Security and abuse protection
Remember your choices and preferences
Statistics
Helps us understand how the website is used so we can improve content, features, and the overall experience. The information is used only in aggregated and anonymised form.
Read more
Visit statistics and page views
Popular features and content
Technical performance
Marketing
Helps us assess whether our communication reaches the right audiences, so relevant jobs are more likely to be shown to the people they are intended for. It may also be used to display embedded third-party content, such as videos and social media posts.
Read more
